IL33 and hepatocellular carcinoma: Therefore, future research will be required, recruiting larger sample sizes, careful design, and more clinical information to identify risk factors for HCC development from CD44 rs187115, IL-33 rs1929992, and ST2 rs3821204 polymorphisms and the underlying biological mechanisms leading to HCC.